Nexstim
Licensing discussions with academic centre endNexstim
Making an impression in depressionNexstim
Warrants to be topped up with share placementNexstim
Q319 update shows therapy business momentumNexstim
A possible new opportunity in severe depressionNexstim
Voluntary loan repayments remove Kreos uncertaintyNexstim
Promising progress with NBTNexstim
Getting back on the front footNexstim
Terms of the rights issue announcedNexstim
Securing the commercial future of NBT in depression